60 related articles for article (PubMed ID: 8589632)
21. Carnitine palmitoyltransferase II activity is decreased in liver mitochondria of cachectic rats bearing the Walker 256 carcinosarcoma: effect of indomethacin treatment.
Seelaender MC; Curi R; Colquhoun A; Williams JF; Zammitt VA
Biochem Mol Biol Int; 1998 Jan; 44(1):185-93. PubMed ID: 9503162
[TBL] [Abstract][Full Text] [Related]
22. Discovery of a long-chain carbamoyl aminocarnitine derivative, a reversible carnitine palmitoyltransferase inhibitor with antiketotic and antidiabetic activity.
Giannessi F; Pessotto P; Tassoni E; Chiodi P; Conti R; De Angelis F; Dell'Uomo N; Catini R; Deias R; Tinti MO; Carminati P; Arduini A
J Med Chem; 2003 Jan; 46(2):303-9. PubMed ID: 12519067
[TBL] [Abstract][Full Text] [Related]
23. Carnitine palmitoyltransferase I activity monitoring in fibroblasts and leukocytes using electrospray ionization mass spectrometry.
Nolte L; van der Westhuizen FH; Pretorius PJ; Erasmus E
Anal Biochem; 1998 Feb; 256(2):178-84. PubMed ID: 9473275
[TBL] [Abstract][Full Text] [Related]
24. Carbacyclin induces carnitine palmitoyltransferase-1 in cardiomyocytes via peroxisome proliferator-activated receptor (PPAR) delta independent of the IP receptor signaling pathway.
Kuroda T; Hirota H; Fujio Y; Sugiyama S; Masaki M; Hiramoto Y; Shioyama W; Okamoto K; Hori M; Yamauchi-Takihara K
J Mol Cell Cardiol; 2007 Jul; 43(1):54-62. PubMed ID: 17540403
[TBL] [Abstract][Full Text] [Related]
25. Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations.
Ørngreen MC; Dunø M; Ejstrup R; Christensen E; Schwartz M; Sacchetti M; Vissing J
Ann Neurol; 2005 Jan; 57(1):60-6. PubMed ID: 15622536
[TBL] [Abstract][Full Text] [Related]
26. Genomic DNA sequence, promoter expression, and chromosomal mapping of rat muscle carnitine palmitoyltransferase I.
Wang D; Harrison W; Buja LM; Elder FF; McMillin JB
Genomics; 1998 Mar; 48(3):314-23. PubMed ID: 9545636
[TBL] [Abstract][Full Text] [Related]
27. Gamma-linolenic acid alters the composition of mitochondrial membrane subfractions, decreases outer mitochondrial membrane binding of hexokinase and alters carnitine palmitoyltransferase I properties in the Walker 256 rat tumour.
Colquhoun A
Biochim Biophys Acta; 2002 Jun; 1583(1):74-84. PubMed ID: 12069851
[TBL] [Abstract][Full Text] [Related]
28. Complementation analysis of carnitine palmitoyltransferase I and II defects.
Slama A; Brivet M; Boutron A; Legrand A; Saudubray JM; Demaugre F
Pediatr Res; 1996 Oct; 40(4):542-6. PubMed ID: 8888280
[TBL] [Abstract][Full Text] [Related]
29. Bezafibrate upregulates carnitine palmitoyltransferase II expression and promotes mitochondrial energy crisis dissipation in fibroblasts of patients with influenza-associated encephalopathy.
Yao M; Yao D; Yamaguchi M; Chida J; Yao D; Kido H
Mol Genet Metab; 2011 Nov; 104(3):265-72. PubMed ID: 21816645
[TBL] [Abstract][Full Text] [Related]
30. Increased carnitine palmitoyltransferase in cardiac myocytes is mediated by insulin growth factor I.
Hudson EK; Wang D; Bieber LL; Buja LM; McMillin JB
Am J Physiol; 1996 Aug; 271(2 Pt 2):H422-7. PubMed ID: 8770079
[TBL] [Abstract][Full Text] [Related]
31. Selective carnitine palmitoyltransferase deficiency in fibroblasts from a patient with muscle CPT deficiency.
Pula TP; Max SR; Zielke HR; Chacon M; Baab P; Gumbinas M; Reed WD
Ann Neurol; 1981 Aug; 10(2):196-8. PubMed ID: 7283405
[TBL] [Abstract][Full Text] [Related]
32. In vivo inhibition of Walker 256 tumour carnitine palmitoyltransferase I by soya oil dietary supplementation.
Colquhoun A; de Mello FE; Curi R
Biochem Mol Biol Int; 1998 Jan; 44(1):151-6. PubMed ID: 9503158
[TBL] [Abstract][Full Text] [Related]
33. Regulation of carnitine palmitoyltransferase in vivo by glucagon and insulin.
Brady PS; Brady LJ
Biochem J; 1989 Mar; 258(3):677-82. PubMed ID: 2543360
[TBL] [Abstract][Full Text] [Related]
34. Turnover of carnitine palmitoyltransferase mRNA and protein in H4IIE cells. Effect of cyclic AMP and insulin.
Wang L; Brady PS; Brady LJ
Biochem J; 1989 Nov; 263(3):703-8. PubMed ID: 2557007
[TBL] [Abstract][Full Text] [Related]
35. Loss of response of carnitine palmitoyltransferase I to okadaic acid in transformed hepatic cells.
Velasco G; Passilly P; Guzmán M; Latruffe N
Biochem Pharmacol; 1998 Dec; 56(11):1485-8. PubMed ID: 9827581
[TBL] [Abstract][Full Text] [Related]
36. Carnitine palmitoyltransferase-1 (CPT-1) activity stimulation by cerulenin via sympathetic nervous system activation overrides cerulenin's peripheral effect.
Jin YJ; Li SZ; Zhao ZS; An JJ; Kim RY; Kim YM; Baik JH; Lim SK
Endocrinology; 2004 Jul; 145(7):3197-204. PubMed ID: 15044358
[TBL] [Abstract][Full Text] [Related]
37. Palmitate-induced cardiac apoptosis is mediated through CPT-1 but not influenced by glucose and insulin.
Kong JY; Rabkin SW
Am J Physiol Heart Circ Physiol; 2002 Feb; 282(2):H717-25. PubMed ID: 11788422
[TBL] [Abstract][Full Text] [Related]
38. Regulation of tumour cell fatty acid oxidation by n-6 polyunsaturated fatty acids.
Colquhoun A; de Mello FE; Curi R
Biochem Mol Biol Int; 1998 Jan; 44(1):143-50. PubMed ID: 9503157
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of neonatal endotoxemia on heart and kidney carnitine palmitoyl transferase I.
Fukumoto K; Pierro A; Spitz L; Eaton S
J Pediatr Surg; 2002 May; 37(5):723-6. PubMed ID: 11987087
[TBL] [Abstract][Full Text] [Related]
40. Regulation of carnitine palmitoyltransferase synthesis in spontaneously diabetic BB Wistar rats.
Brady LJ; Brady PS
Diabetes; 1989 Jan; 38(1):65-9. PubMed ID: 2909413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
